US Patent 10174091 IL-2 muteins
Patent 10174091 was granted and assigned to Pandion Therapeutics on January, 2019 by the United States Patent and Trademark Office.
Is a
Current Assignee
Date Filed
August 23, 2018
Date of Patent
January 8, 2019
Patent Applicant
Patent Application Number
16109875
Patent Citations Received
•••
Patent Jurisdiction
Patent Number
Patent Primary Examiner
Find more entities like US Patent 10174091 IL-2 muteins
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
